# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate abo...
Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical l...
Argus Research analyst David Toung upgrades Laboratory Corp (NYSE:LH) from Hold to Buy.
Outcomes point to value of biomarker testing in addressing testing gaps in clinical practice
The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians wi...
Leerink Partners analyst Michael Cherny initiates coverage on Laboratory Corp (NYSE:LH) with a Outperform rating and announc...